Skip Ribbon Commands
Skip to main content
Skip over global navigation links
U.S. Department of Health and Human Services

Assistant Secretary Robert Kadlec announces new BARDA Director

November 19, 2020


I am pleased to announce today the selection of Gary Disbrow, PhD, as Deputy Assistant Secretary for Preparedness and Response and Director of the Biomedical Advanced Research and Development Authority (BARDA). BARDA, a component of the Office of the Assistant Secretary for Preparedness and Response within the U.S. Department of Health and Human Services, invests in the innovation, advanced research and development, acquisition, and manufacturing of medical countermeasures – vaccines, drugs, therapeutics, diagnostic tools, and non-pharmaceutical products – needed to combat 21st century health security threats. 


Dr. Disbrow has been serving  as the Acting BARDA Director and Deputy Assistant Secretary for Preparedness and Response since April 2020.  Dr. Disbrow brings with him a wealth of experience. He joined BARDA in January 2007 and during his tenure, BARDA-supported public-private sector partnerships have earned 56 regulatory approvals, licensures or clearances through the U.S. Food and Drug Administration.  During this time, BARDA has established a portfolio of more than 70 medical countermeasure projects in the fight against COVID-19, including seven potential vaccine candidates, 37 diagnostics, and 11 therapeutics.


Prior to becoming the Acting BARDA Director, Dr. Disbrow served as both the Director and Acting Director of the BARDA Chemical, Biological, Radiological and Nuclear (CBRN) Division. During that time, Dr. Disbrow led the CBRN budget and programs for both advanced research and development and Project BioShield. Dr. Disbrow joined the BARDA team in 2007 and has served in a wide variety of positions that strengthened health security, including programs to fight smallpox, Zika and Ebola.


BARDA is an integral part of the all-of-America response to the COVID-19 pandemic, and we have Dr. Disbrow and the BARDA staff to thank for so much of the progress to date in developing diagnostics, therapeutics and vaccines to combat this virus.


Respectfully,
Robert Kadlec
Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services


  • This page last reviewed: November 19, 2020